Recognizing July 28, 2026, as "World Hepatitis Day".
The source supplies the latest action, but no lifecycle stage.
Latest action (23 Jul 2026): Referred to the House Committee on Energy and Commerce.
What this bill does
This House resolution would recognize July 28, 2026, as "World Hepatitis Day." It aims to highlight the global impact of hepatitis B and C, which are leading causes of liver cancer and death worldwide. The resolution supports increasing access to vaccinations and treatments, raising awareness about the risks of undiagnosed infections, and calls for a strong public health response to protect the estimated 5.9 million people in the United States affected by hepatitis.
The resolution specifically mentions that many individuals, including certain racial and ethnic groups, intravenous drug users, and gay and bisexual men, have higher rates of chronic viral hepatitis infections. It also notes that a significant number of people living with hepatitis B and C in the U.S. are unaware of their condition, and less than a third of those with hepatitis C receive treatment.
This bill was introduced in the House of Representatives and referred to the Committee on Energy and Commerce. As a resolution, if passed by the House, it would express the sense of Congress. It does not require Senate approval or the President's signature to become effective in recognizing the day.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Timeline
23 Jul 2026
Referred to the House Committee on Energy and Commerce.
Common questions
- What does H.Res. 1458 do?
- This House resolution would recognize July 28, 2026, as "World Hepatitis Day." It aims to highlight the global impact of hepatitis B and C, which are leading causes of liver cancer and death worldwide. The resolution supports increasing access to vaccinations and treatments, raising awareness about the risks of undiagnosed infections, and calls for a strong public health response to protect the estimated 5.9 million people in the United States affected by hepatitis. The resolution specifically mentions that many individuals, including certain racial and ethnic groups, intravenous drug users, and gay and bisexual men, have higher rates of chronic viral hepatitis infections. It also notes that a significant number of people living with hepatitis B and C in the U.S. are unaware of their condition, and less than a third of those with hepatitis C receive treatment. This bill was introduced in the House of Representatives and referred to the Committee on Energy and Commerce. As a resolution, if passed by the House, it would express the sense of Congress. It does not require Senate approval or the President's signature to become effective in recognizing the day.
- Has H.Res. 1458 become law?
- The source does not supply a confirmed lifecycle stage for H.Res. 1458. Check the latest action and official source below.
- Who sponsored H.Res. 1458?
- H.Res. 1458 was sponsored by Rep. Velázquez, Nydia M. [D-NY-7] (D-NY), with 1 cosponsor.
- What's the latest action on H.Res. 1458?
- Referred to the House Committee on Energy and Commerce. (23 Jul 2026).
Related bills in Health
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Choices for Increased Mobility Act of 2026
Access to Medical Supplies Act
Lower Premiums, Faster Payments Act
More bills from Rep. Velázquez, Nydia M. [D-NY-7]
504 Modernization and Small Manufacturer Enhancement Act of 2026
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Small Business Administration relating to "Citizenship and Residency Requirements and Recission of Procedural Notice 5000-872050" and "Revised Applicant Ownership, Citizenship, and Residency Requirements for 7(a) and 504 Loans".
Businessowner Immigration Rights and Responsibilities Information Act of 2026
Maintaining Small Business Engagement Act of 2026
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.